Dietary supplement recalled, FDA says

Silintan capsules are recalled after the Food and Drug Administration found they were tainted with another drug.
MedPage Today on MSN

FDA Moves to 'Get Out of the Way' of Wearables, AI in the Clinic

Torous noted that over the summer, a company called WHOOP received an FDA warning letter over a product that could measure ...
Fierce Biotech

Madrigal pays $50M for Pfizer MASH drug with eye on Rezdiffra combo potential

Madrigal has paid Pfizer $50 million for the rights to a DGAT2i inhibitor with the intention of combining the drug with its ...
CURE

FDA Grants Breakthrough Status to Zoldonrasib in Lung Cancer

Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...

FDA approves Myqorzo for symptomatic obstructive hypertrophic cardiomyopathy

The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic ...
PharmiWeb

INTENT Biologics Receives FDA Fast Track Designation for PEP Biologic™

INTENT Biologics, a clinical-stage biotechnology company developing first-in-class exosome-based biologic therapies for ...
BioSpace

Despite MFN Deals, Drug Pricing Will Dog Pharma Into 2026

Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller ...
Manila Standard

FDA reports 2025 milestones, reforms enforcement plans

The Food and Drug Administration (FDA) capped 2025 with a year-end report on Thursday, highlighting reforms, enforcement ...

Complement Therapeutics Announces FDA Fast Track Designation for CTx001 for the Treatment of Geographic Atrophy Secondary to AMD

Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...

VectorY Therapeutics Receives FDA Fast Track Designation for VTx-002, a First-in-Class Vectorized Antibody Targeting Underlying Disease Biology in ALS

VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the U.S.

4Moving Biotech Receives FDA IND Clearance for 4P004, Strengthening Its Position as a Leading Innovator in Disease-Modifying Osteoarthritis Therapeutics

Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for osteoarthritis (OA), today announced that the U.S. Food and Drug Administration ...
Opinion
PharmabizOpinion

India falls short of global norms in pharmacist-supervised OTC drug dispensing: Dr Premnath Shenoy

India falls short of global norms in pharmacist-supervised OTC drug dispensing: Dr Premnath Shenoy: Nandita Vijayasimha Bengaluru Friday, January 9, 2026, 08:00 Hrs [IST] India fa ...